v3.22.4
Collaborations (Tables)
 12 Months Ended
Dec. 31, 2022
Janssen Biotech, Inc  
Collaborative Arrangements and Non-collaborative Arrangement Transactions  
Schedule of profit and cost sharing relationship The following table shows the profit and cost sharing relationship between Janssen and AbbVie:
years ended December 31 (in millions)202220212020
United States - Janssen's share of profits (included in cost of products sold)$1,607 $2,018 $2,012 
International - AbbVie's share of profits (included in net revenues)1,142 1,087 1,009 
Global - AbbVie's share of other costs (included in respective line items)268 304 295 
Genentech, Inc.  
Collaborative Arrangements and Non-collaborative Arrangement Transactions  
Schedule of profit and cost sharing relationship The following table shows the profit and cost sharing relationship between Genentech and AbbVie:
years ended December 31 (in millions)202220212020
Genentech's share of profits, including royalties (included in cost of products sold)$778 $703 $533 
AbbVie's share of sales and marketing costs from U.S. collaboration (included in SG&A)37 40 46 
AbbVie's share of development costs (included in R&D)121 140 129